does tirzepatide cause naion Mounjaro (tirzepatide) have the same risk of non‑arteritic anterior ischemic optic neuropathy (NAION) as semaglutide (Ozempic)? No Causal Link Discernable for

Your doctor can provide guidance on managing these side effects and help determine the best course of action

Staying on a low maintenance dose of Ozempic (0.25 or 0.5 mg weekly) long-term is a reasonable strategy for many people

Using a linear trimming estimator in the trim and fill model, one study was credited on the right side of the funnel plot

A similar pattern was observed in the SURMOUNT-4 trial for tirzepatide: after participants lost an average of 20.9% of their body weight during a 36-week lead-in phase, those who stopped treatment regained about 14%, while those who continued taking tirzepatide lost an additional 5.5% over the next year

received honoraria as a speaker for AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Elpen, Galenica, GSK, MSD, Mylan, Novartis, Novo Nordisk, Pfizer, Sanofi Aventis, Takeda and Vianex